They demonstrated that iCAF formation is induced by tumor-secreted IL-1 that activates a LIF/JAK/STAT-dependent cytokine cascade, whereas tumor-secreted TGF-β antagonizes JAK/STAT signaling by IL-1R1 downregulation and promotes differentiation into myCAF. Here, IL1R1 is linked to neoplasm.